Physician profile
Joseph Russo
NPI 1598732240
$270,335.79
in general payments reported to CMS, 2019-2025
8 companies · $34K in 2025
The $34K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,646 · 2021: $115K · 2022: $18K · 2023: $43K · 2024: $41K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $106K · Food and Beverage: $8,522 · Travel and Lodging: $3,688 · Education: $27.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $106,459.70 |
| Food and Beverage | $8,521.52 |
| Travel and Lodging | $3,687.94 |
| Education | $27.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $141,718.89 | 2019-2022 | |
| Abbvie INC. | $108,181.33 | 2022-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Galderma Laboratories, L.P. | $9,996.02 | 2022-2025 | Dysport |
| Merz North America, INC. | $9,884.91 | 2019-2025 | |
| Revance Therapeutics, INC. | $282.81 | 2024-2025 | Daxxify |
| Sientra, INC. | $238.43 | 2021-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $17.91 | 2024 | Clear+Brilliant |
| Mentor Worldwide LLC | $15.49 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.